PaperInfluenza vaccination in 22 developed countries: an update to 1995
References (19)
- et al.
Influenza vaccination in 18 developed countries, 1980–1992
Vaccine
(1995) - et al.
Influenza immunization polices in Europe and the United States
Vaccine
(1995) - et al.
Healthcare financing for the elderly in Japan
Social Science and Medicine
(1993) - et al.
Scepticism about influenza vaccine efficacy in Japan (letter)
Lancet
(1994) - et al.
Japan lagging in influenza jabs
Nature
(1996) - et al.
Influenza immunization polices in Europe and the United States
Pneumococcal and influenza vaccination levels among adults ≥65 years—United States, 1993
MMWR Morbidity and Mortality Weekly Report
(1996)Implementation of the Medicare influenza vaccination benefit
MMWR Morbidity and Mortality Weekly Report
(1994)- et al.
The effectiveness of vaccination against influenza in healthy, working adults
New England Journal of Medicine
(1995)
Cited by (84)
Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China
2021, VaccineCitation Excerpt :Given that nearly 90% of the elderly in Shenzhen who received influenza vaccines also received PPSV23 and that very few people received either of the vaccines outside of the immunization program, we did not compare dual vaccination with either vaccine alone in this study to avoid substantial deviation from real-world practice. Subsidizing vaccination is important for the uptake of influenza and pneumococcal vaccines [43]. In some countries, especially those providing free influenza and pneumococcal vaccines, the vaccination rates are relatively high.
Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis
2016, VaccineCitation Excerpt :Thus, vaccine uptake in China falls substantially below the World Health Assembly (WHA) target of 75% in the elderly by 2010 [12], and also below that of other upper-middle income countries such as Brazil where coverage is over 70% in the elderly [6]. In countries where vaccination costs are subsidized by the respective governments, there is higher national vaccine uptake [13,14]. To our knowledge, only a handful of large cities in China currently provide reimbursement for influenza vaccination.
Influenza vaccination in Austria from 1982 to 2011: A country resistant to influenza prevention and control
2013, VaccineCitation Excerpt :In 1996, the European Scientific Working Group on Influenza (ESWI) took over the project. The work of these groups led to four publications [14–17], which have provided a foundation for understanding the macro-epidemiology of influenza vaccination throughout the world. Data from this source cover the years from 1980 to 2003 in three study periods: 1980–1992, 1992–1995, and 1996–2003.
Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India
2010, Infection, Genetics and EvolutionCitation Excerpt :The results reconfirms importance of Influenza surveillance is of utmost importance in the south-east and eastern Asian countries, since it is predicted that this region “seeds” the subsequent annual seasonal epidemics (Ahmad et al., 2000). As strains from Taiwan (Fedson et al., 1997) as well as Eastern India precede vaccine strains, contribution of strains from this region to the Global Influenza Surveillance Network (GISN) is important. However, plethora of information on HA and NA gene sequences from different locations of India as well as other Asian countries are required for significant contribution in GISN.
In a prospective observational study, influenza vaccination prevented hospitalization among older home care patients
2006, Journal of Clinical Epidemiology